Downregulation of Matrix Metalloproteinases and Collagens and Suppression of Cardiac Fibrosis by Inhibition of the Proteasome

Hypertension - United States
doi 10.1161/01.hyp.0000142772.71367.65
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Role of Matrix Metalloproteinases and Therapeutic Benefits of Their Inhibition in Spinal Cord Injury

Neurotherapeutics
NeurologyPharmacology
2011English

Inhibition of Platelet Activation by Clopidogrel Prevents Hypertension-Induced Cardiac Inflammation and Fibrosis

Cardiovascular Drugs and Therapy
MedicineCardiovascular MedicinePharmacologyCardiology
2013English

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2003English

Matrix Metalloproteinases and Epileptogenesis

Molecular and Cellular Pediatrics
Child HealthPediatricsPerinatologyMolecular BiologyCell Biology
2014English

Platelets and Matrix Metalloproteinases

Thrombosis and Haemostasis
Hematology
2013English

Inhibition of Matrix Metalloproteinases Expression in Human Dental Pulp Cells by All-Trans Retinoic Acid

International journal of oral science
Dentistry
2013English

Primary Proteasome Inhibition Results in Cardiac Dysfunction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2013English

Enhancement of Cardiac Function and Suppression of Heart Failure Progression by Inhibition of Protein Phosphatase 1

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2005English

Fetal Hypoxia and Programming of Matrix Metalloproteinases

Drug Discovery Today
Drug DiscoveryPharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy